umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Possible involvement of the endocannabinoid system in the actions of three clinically used drugs.
Umeå University, Faculty of Medicine, Pharmacology and Clinical Neuroscience, Pharmacology.
2004 (English)In: Trends in pharmacological sciences, ISSN 0165-6147, Vol. 25, no 2, 59-61 p.Article in journal (Other academic) Published
Place, publisher, year, edition, pages
2004. Vol. 25, no 2, 59-61 p.
Keyword [en]
Anesthetics; Intravenous/*pharmacology, Animals, Anti-Inflammatory Agents; Non-Steroidal/*pharmacology, Drug Interactions, Endocannabinoids/*metabolism, Flurbiprofen/*pharmacology, Indomethacin/*pharmacology, Mice, Propofol/*pharmacology, Receptors; Cannabinoid/drug effects/metabolism
Identifiers
URN: urn:nbn:se:umu:diva-5865PubMedID: 15106622OAI: oai:DiVA.org:umu-5865DiVA: diva2:145533
Available from: 2008-01-09 Created: 2008-01-09 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15106622&dopt=Citation
By organisation
Pharmacology

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 23 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf